How long till Wegovy starts working — and what 'working' actually means

The biggest misconception: Wegovy should be visibly working by week one

A question our prescribers hear most weeks goes something like this: "I've had my first injection and I don't feel any different, is it even doing anything?" It's a fair worry. The assumption that a medicine this talked-about should announce itself dramatically from day one is completely understandable, and completely wrong.

Wegovy's active ingredient, semaglutide, works by activating GLP-1 receptors involved in appetite regulation and the feeling of fullness. But the licensed dosing schedule starts at 0.25mg, a level chosen to let your body adjust and reduce the risk of nausea, not to produce immediate therapeutic weight loss. Think of the first four weeks as your system recalibrating, not as a missed opportunity. Some people do notice a quieter appetite even at 0.25mg; others feel very little until the dose steps up. Both experiences sit within the normal range.

The NHS patient information on semaglutide confirms this phased approach and explains why titration matters. Rushing through doses or expecting dramatic early results tends to lead to disappointment, or, worse, stopping treatment before it has had the chance to work properly.

What actually happens in weeks one through sixteen

Weeks one to four are typically about tolerability. The 0.25mg starter dose settles in; the most common side effects (nausea, some digestive disruption, mild fatigue) peak around dose increases and usually ease within days. Weight change at this stage is often modest.

By weeks four to eight, most people have moved to 0.5mg and then 1mg, and appetite suppression becomes more noticeable. Portion sizes feel smaller naturally; cravings for calorie-dense foods tend to ease. If you are wondering how long before Wegovy starts to work in a way you can actually feel, this four-to-eight week window is usually when people begin to notice a real difference. This is when the scales often begin to move more consistently, though the rate varies between individuals.

Weeks eight to sixteen see continued dose increases toward the 1.7mg and eventually 2.4mg maintenance level. For many people this is when monthly weight loss accelerates. You can read a fuller breakdown of the expected weekly changes on our dedicated page on how long Wegovy takes to work.

Clinical trial data supports this arc. In the STEP 1 trial, published in the New England Journal of Medicine, adults receiving semaglutide 2.4mg lost an average of around 15% of their starting body weight over 68 weeks, roughly 16 months. The weight loss curve was steepest in the first six months and then continued at a slower but steady rate. That 68-week figure is worth sitting with: it is the full treatment period, not the first month.

The six-month checkpoint and what it means for your treatment

NICE guidance for semaglutide (TA875) includes a practical benchmark: if fewer than 5% of starting body weight has been lost after six months at the maintenance dose, continuing the medicine should be reviewed. This exists to protect patients, not to pressure them. For most people who tolerate the dose escalation and engage with dietary changes, 5% at six months is a realistic milestone.

Context matters here. If you are trying to understand how long it will take for Wegovy to start working in a meaningful way, the answer depends on where in the titration you are, because six months means six months at or near the 2.4mg maintenance level, not six months from the very first injection when you were still on 0.25mg. The titration period is not the treatment, it is the approach to it.

If you are thinking about what Wegovy costs during this period, our treatment page sets out what a private prescription includes. The relevant question for a prescription medicine is not which provider is cheapest but whether clinical oversight, genuine supply and proper aftercare are in place throughout what is, ultimately, a months-long course.

Factors that affect how quickly you see results

Starting weight, metabolic rate, diet quality during treatment, activity levels and how well nausea is managed all influence the pace. There is no single timeline that fits everyone. People with type 2 diabetes, for example, often see somewhat slower weight reduction than those without, a pattern observed in the STEP clinical programme.

The 7.2mg higher-dose pen, approved by the MHRA in April 2026, has reported average weight loss of around 20.7% over 72 weeks in trials, approaching the results seen with tirzepatide. Whether that dose is appropriate is a clinical decision made with your prescriber, not something to pursue based on wanting faster results. A broader look at what Wegovy is and how it is used in the UK covers the full licensed schedule.

One more thing worth stating plainly: Wegovy works best alongside changes in eating habits and physical activity. The trials that produced those headline figures ran alongside structured lifestyle support. Many patients also find it helpful to read about how long before Wegovy starts working at each dose stage, so they know what to expect as their eating habits and physical activity begin to interact with the medicine. Our clinical team can talk through what realistic progress looks like for your specific situation.

Curious whether your starting BMI and health history put you in range for treatment? Our prescribers can assess that properly, and they can also advise on how long until Wegovy starts working given your individual circumstances. Speak to our prescribers through a free consultation, reviewed the same day by a real clinician, not software.